Practical implications for the administration of 13-cis retinoic acid in pediatric oncology

International Journal of Clinical Pharmacy

Volumn 33, Issue 4, 2011, Pages 597-598

  Bauters, Tiene G M ^a   Laureys, Geneviève ^a   Van De Velde, Véronique ^a   Benoit, Yves ^a   Robays, Hugo ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

13 cis retinoic acid; Clinical pharmacy; Pediatric oncology

Indexed keywords

ISOTRETINOIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHILDHOOD CANCER; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DEGRADATION; DRUG FORMULATION; DRUG STORAGE; ENTERIC FEEDING; HIGH RISK PATIENT; HUMAN; LIPID DIET; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SWALLOWING; TREATMENT DURATION;

ADMINISTRATION, ORAL; CHILD; DEGLUTITION; ENTERAL NUTRITION; HUMANS; ISOTRETINOIN; MEDICAL ONCOLOGY; NEUROBLASTOMA;

EID: 80052406737     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9519-9     Document Type: Article

References (13)

1. JM Maris 2010 Recent advances in neuroblastoma N Engl J Med 362 23 2202 2211 20558371 10.1056/NEJMra0804577 1:CAS:528:DC%2BC3cXnsV2htr0%3D
2. JL Armstrong CP Redfern GJ Veal 2005 13-cis retinoic acid and isomerisation in paediatric oncology-is changing shape the key to success? Biochem Pharmacol 69 9 1299 1306 15826600 10.1016/j.bcp.2005.02.003 1:CAS:528:DC%2BD2MXjtFyqsLw%3D (Pubitemid 40514388)
3. E-Compendium. Scientific Leaflet Roaccutane (in Flemish). Available from URL: http:/ www.ecompendium.be/. Accessed 4 Oct 2010.
4. K Matthay C Reynolds R Seeger H Shimada E Stanton Adkins, et al. 2009 Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a Children's Oncology Group Study J Clin Oncol 27 7 1007 1013 19171716 10.1200/JCO.2007.13.8925 1:CAS:528:DC%2BD1MXktVCjurY%3D
5. GJ Veal M Cole J Errington A Pearson A Foot G Whyman A Boddy 2007 Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma-a study of the United Kingdom Children's Cancer Study Group Br J Cancer 96 3 424 431 17224928 10.1038/sj.bjc.6603554 1:CAS:528:DC%2BD2sXhtlKjtrY%3D (Pubitemid 46215212)
6. LM Wagner MK Danks 2009 New therapeutic targets for the treatment of high-risk neuroblastoma J Cell Biochem 107 1 46 57 19277986 10.1002/jcb.22094 1:CAS:528:DC%2BD1MXlsFymtLg%3D
7. European Medicines Agency. List of paediatric needs oncology I. Available from URL: http://www.emea.europa.eu/docs/en-GB/document-library/Other/2009/10/ WC500004052.pdf. Accessed 18 Dec 2010.
8. Priority List of Needs in Pediatric Therapeutics for 2008-2009. National institutes of child health and human development. Available from URL: http://bpca.nichd.nih.gov/about/process/upload/2009-Summary-091509.pdf. Accessed 18 Dec 2010.
9. WA Colburn DM Gibson RE Wiens JJ Hanigan 1983 Food increases the bioavailability of isotretinoin J Clin Pharmacol 23 11-12 534 539 6582073 1:CAS:528:DyaL2cXlsFSgtLg%3D (Pubitemid 14220900)
10. CJ Barnes LF Eichenfield J Lee BB Cunningham 2005 A practical approach for the use of oral isotretinoin for infantile acne Pediatr Dermatol 22 2 166 169 15804310 10.1111/j.1525-1470.2005.22224.x (Pubitemid 40471486)
11. LE Schmidt K Dalhoff 2002 Food-drug interactions Drugs 62 10 1481 1502 12093316 10.2165/00003495-200262100-00005 1:CAS:528:DC%2BD38XmsVGlt7w%3D (Pubitemid 34804156)
12. R Ganceviciene CC Zouboulis 2010 Isotretinoin: state of the art treatment for acne vulgaris J Dtsch Dermatol Ges. 8 S1 S47 S59 20482692
13. HS Lin WW Leong JA Yang P Lee SY Chan PC Ho 2007 Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified beta-cyclodextrins Int J Pharm 341 1-2 238 245 17482391 10.1016/j.ijpharm.2007.03.050 1:CAS:528:DC%2BD2sXot1Clsrw%3D (Pubitemid 47088113)